{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T19:38:09Z","timestamp":1792525089269,"version":"4.5.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,20]]},"DOI":"10.7759\/cureus.118258","type":"journal-article","created":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T18:38:31Z","timestamp":1792521511000},"source":"Crossref","is-referenced-by-count":0,"title":["Anticoagulation Monitoring in Recurrent Venous Thromboembolism Associated With Antiphospholipid Antibodies and Subsequent Heparin-Induced Thrombocytopenia"],"prefix":"10.7759","author":[{"given":"George","family":"Bechir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2024000547","article-title":"Warfarin and heparin monitoring in antiphospholipid syndrome","volume":"2024","author":"Mittal P","year":"2024","unstructured":"Mittal P, Sayar Z, Cohen H. Warfarin and heparin monitoring in antiphospholipid syndrome. Hematology Am Soc Hematol Educ Program. 2024, 2024:192-9. 10.1182\/hematology.2024000547","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.19635","article-title":"Guidelines on the investigation and management of antiphospholipid syndrome","volume":"205","author":"Arachchillage DJ","year":"2024","unstructured":"Arachchillage DJ, Platton S, Hickey K, et al.. Guidelines on the investigation and management of antiphospholipid syndrome. Br J Haematol. 2024, 205:855-80. 10.1111\/bjh.19635","journal-title":"Br J Haematol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2018024489","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia","volume":"2","author":"Cuker A","year":"2018","unstructured":"Cuker A, Arepally GM, Chong BH, et al.. American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia. Blood Adv. 2018, 2:3360-92. 10.1182\/bloodadvances.2018024489","journal-title":"Blood Adv"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2009.03335.x","article-title":"False-positive tests for heparin-induced thrombocytopenia in patients with antiphospholipid syndrome and systemic lupus erythematosus","volume":"7","author":"Pauzner R","year":"2009","unstructured":"Pauzner R, Greinacher A, Selleng K, Althaus K, Shenkman B, Seligsohn U. False-positive tests for heparin-induced thrombocytopenia in patients with antiphospholipid syndrome and systemic lupus erythematosus. J Thromb Haemost. 2009, 7:1070-4. 10.1111\/j.1538-7836.2009.03335.x","journal-title":"J Thromb Haemost"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2023-224609","article-title":"2023 ACR\/EULAR antiphospholipid syndrome classification criteria","volume":"82","author":"Barbhaiya M","year":"2023","unstructured":"Barbhaiya M, Zuily S, Naden R, et al.. 2023 ACR\/EULAR antiphospholipid syndrome classification criteria. Ann Rheum Dis. 2023, 82:1258-70. 10.1136\/ard-2023-224609","journal-title":"Ann Rheum Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1309\/AJCPS6OW6DYNOGNH","article-title":"Activated partial thromboplastin time and anti-Xa measurements in heparin monitoring: biochemical basis for discordance","volume":"139","author":"Takemoto CM","year":"2013","unstructured":"Takemoto CM, Streiff MB, Shermock KM, Kraus PS, Chen J, Jani J, Kickler T. Activated partial thromboplastin time and anti-Xa measurements in heparin monitoring: biochemical basis for discordance. Am J Clin Pathol. 2013, 139:450-6. 10.1309\/AJCPS6OW6DYNOGNH","journal-title":"Am J Clin Pathol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1309\/D79K-4YG7-8NTN-YY38","article-title":"Effect of direct thrombin inhibitors, bivalirudin, lepirudin, and argatroban, on prothrombin time and INR values","volume":"121","author":"Gosselin RC","year":"2004","unstructured":"Gosselin RC, Dager WE, King JH, Janatpour K, Mahackian K, Larkin EC, Owings JT. Effect of direct thrombin inhibitors, bivalirudin, lepirudin, and argatroban, on prothrombin time and INR values. Am J Clin Pathol. 2004, 121:593-9. 10.1309\/D79K-4YG7-8NTN-YY38","journal-title":"Am J Clin Pathol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1R635","article-title":"Discordant aPTT and anti-Xa values and outcomes in hospitalized patients treated with intravenous unfractionated heparin","volume":"47","author":"Price EA","year":"2013","unstructured":"Price EA, Jin J, Nguyen HM, Krishnan G, Bowen R, Zehnder JL. Discordant aPTT and anti-Xa values and outcomes in hospitalized patients treated with intravenous unfractionated heparin. Ann Pharmacother. 2013, 47:151-8. 10.1345\/aph.1R635","journal-title":"Ann Pharmacother"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.03178.x","article-title":"Laboratory control of oral anticoagulant treatment by the INR system in patients with the antiphospholipid syndrome and lupus anticoagulant. Results of a collaborative study involving nine commercial thromboplastins","volume":"115","author":"Tripodi A","year":"2001","unstructured":"Tripodi A, Chantarangkul V, Clerici M, Negri B, Galli M, Mannucci PM. Laboratory control of oral anticoagulant treatment by the INR system in patients with the antiphospholipid syndrome and lupus anticoagulant. Results of a collaborative study involving nine commercial thromboplastins. Br J Haematol. 2001, 115:672-8. 10.1046\/j.1365-2141.2001.03178.x","journal-title":"Br J Haematol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1591029","article-title":"Impact of thromboplastin reagents on monitoring INR in a patient with triple-positive antiphospholipid syndrome: a case report","volume":"16","author":"Varju L","year":"2025","unstructured":"Varju L, Bagoly Z, Ajzner \u00c9, Orb\u00e1n-K\u00e1lm\u00e1ndi R, K\u00e1d\u00e1r AZ, Nevel\u0151s J, Ilonczai P. Impact of thromboplastin reagents on monitoring INR in a patient with triple-positive antiphospholipid syndrome: a case report. Front Immunol. 2025, 16:10.3389\/fimmu.2025.1591029","journal-title":"Front Immunol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1177\/00031348251341952","article-title":"Early experience using venous sheath with embolic protection during thrombectomy of inferior vena cava and complex iliofemoral deep vein thrombosis","author":"Hegazi M","year":"2025","unstructured":"Hegazi M, Nguyen PD, Kabutey NK, et al.. Early experience using venous sheath with embolic protection during thrombectomy of inferior vena cava and complex iliofemoral deep vein thrombosis. Am Surg. 2025, 10.1177\/00031348251341952","journal-title":"Am Surg"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2008.03025.x","article-title":"Quantitative interpretation of optical density measurements using PF4-dependent enzyme-immunoassays","volume":"6","author":"Warkentin TE","year":"2008","unstructured":"Warkentin TE, Sheppard JI, Moore JC, Sigouin CS, Kelton JG. Quantitative interpretation of optical density measurements using PF4-dependent enzyme-immunoassays. J Thromb Haemost. 2008, 6:1304-12. 10.1111\/j.1538-7836.2008.03025.x","journal-title":"J Thromb Haemost"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/3423548","article-title":"Coexistence of antiphospholipid syndrome and heparin-induced thrombocytopenia in a patient with recurrent venous thromboembolism","volume":"2017","author":"Adediran S","year":"2017","unstructured":"Adediran S, Agostino N. Coexistence of antiphospholipid syndrome and heparin-induced thrombocytopenia in a patient with recurrent venous thromboembolism. Case Rep Hematol. 2017, 2017:10.1155\/2017\/3423548","journal-title":"Case Rep Hematol"},{"key":"ref14","article-title":"Monitoring direct thrombin inhibitors with a plasma diluted thrombin time","volume":"98","author":"Love JE","year":"2007","unstructured":"Love JE, Ferrell C, Chandler WL. Monitoring direct thrombin inhibitors with a plasma diluted thrombin time. Thromb Haemost. 2007, 98:234-42.","journal-title":"Thromb Haemost"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-09-599498","article-title":"Fondaparinux for the treatment of suspected heparin-induced thrombocytopenia: a propensity score-matched study","volume":"125","author":"Kang M","year":"2015","unstructured":"Kang M, Alahmadi M, Sawh S, Kovacs MJ, Lazo-Langner A. Fondaparinux for the treatment of suspected heparin-induced thrombocytopenia: a propensity score-matched study. Blood. 2015, 125:924-9. 10.1182\/blood-2014-09-599498","journal-title":"Blood"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-215213","article-title":"EULAR recommendations for the management of antiphospholipid syndrome in adults","volume":"78","author":"Tektonidou MG","year":"2019","unstructured":"Tektonidou MG, Andreoli L, Limper M, et al.. EULAR recommendations for the management of antiphospholipid syndrome in adults. Ann Rheum Dis. 2019, 78:1296-304. 10.1136\/annrheumdis-2019-215213","journal-title":"Ann Rheum Dis"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz405","article-title":"2019 ESC guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): the Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC)","volume":"41","author":"Konstantinides SV","year":"2020","unstructured":"Konstantinides SV, Meyer G, Becattini C, et al.. 2019 ESC guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): the Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC). Eur Heart J. 2020, 41:543-603. 10.1093\/eurheartj\/ehz405","journal-title":"Eur Heart J"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/536731-anticoagulation-monitoring-in-recurrent-venous-thromboembolism-associated-with-antiphospholipid-antibodies-and-subsequent-heparin-induced-thrombocytopenia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T18:38:32Z","timestamp":1792521512000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/536731-anticoagulation-monitoring-in-recurrent-venous-thromboembolism-associated-with-antiphospholipid-antibodies-and-subsequent-heparin-induced-thrombocytopenia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,20]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.118258","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10,20]]}}}